Skip to content
Human Body Study

Gut–Brain & Energy-Balance Signaling

Gut–brain & energy-balance signalling Peripheral signals from adipose tissue (leptin), the small intestine (GLP-1, PYY, CCK, GIP), the pancreas (insulin as a central adiposity signal), and the stomach (ghrelin) converge on the hypothalamic arcuate nucleus. POMC/CART neurons in the arcuate are anorexigenic and respond to satiety signals; NPY/AgRP neurons are orexigenic and respond to hunger signals. Outputs regulate food intake, energy expenditure, and glucose metabolism. The system defends body weight asymmetrically — it resists weight loss more strongly than weight gain. Adipose tissue adiposity sensor Small intestine post-prandial L-cells, K-cells Pancreas β-cells · central insulin signal Stomach empty-stomach · pre-meal Arcuate nucleus (hypothalamus) POMC / CART satiety (anorexigenic) NPY / AgRP hunger (orexigenic) + brainstem NTS integration leptin (−) hunger GLP-1 · PYY · CCK GIP · oxyntomodulin (−) hunger insulin (−) hunger ghrelin (+) hunger net behavioural & metabolic output Food intake · energy expenditure · glucose metabolism ↑ meal-to-meal appetite control (short-term) ↑ defence of body fat stores (long-term) Asymmetric defence — resists weight loss more strongly than weight gain. GLP-1 receptor agonists (semaglutide, tirzepatide) exploit the satiety side of this circuit. Vagal afferents and brainstem NTS also contribute — not shown here.

Signaling chain

Section titled “Signaling chain”

A distributed network rather than a single linear axis. Peripheral signals from the gut and adipose tissue report nutritional and energy status to the hypothalamus (chiefly the arcuate nucleus) and brainstem:

  • Leptin — from adipose tissue; signals long-term fat stores (satiety/adiposity signal).
  • Ghrelin — from the stomach; the main orexigenic (“hunger”) hormone, rises before meals.
  • GLP-1, PYY, CCK, GIP, oxyntomodulin — gut-derived incretin/satiety hormones released in response to a meal.
  • Insulin — also acts centrally as an adiposity signal.

Function

Section titled “Function”

Integrates short-term meal-to-meal appetite control with long-term energy homeostasis and body-weight regulation. The arcuate nucleus balances orexigenic (NPY/AgRP) against anorexigenic (POMC/CART) neurons; output influences food intake, energy expenditure, and glucose metabolism.

Feedback

Section titled “Feedback”

Falling energy stores reduce leptin and raise ghrelin, driving hunger and conserving energy; feeding and rising fat mass do the reverse. The system defends body weight asymmetrically — it resists weight loss more strongly than weight gain.

Clinical relevance

Section titled “Clinical relevance”
  • Obesity — often associated with leptin resistance.
  • Congenital leptin deficiency — rare, causes severe early-onset obesity (responsive to leptin).
  • GLP-1 receptor agonists (semaglutide, tirzepatide) — major pharmacologic advance for obesity and type 2 diabetes.
  • Bariatric surgery alters gut-hormone profiles favorably.

Key labs

Section titled “Key labs”

No routine clinical panel; leptin and ghrelin are mostly research assays. Energy balance is assessed via BMI, body composition, and metabolic testing.